Home / Recursion Pharmaceuticals, Inc. (RXRX)

Updated: 2026-03-17 00:38 UTC · Last close: 3.39 (-0.88%)

Recursion Pharmaceuticals, Inc. (RXRX) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

Recursion Pharmaceuticals, Inc. (RXRX) finished the session at 3.39 (-0.88%). With price below both the 50-day and 200-day moving averages, the broader structure still reflects elevated technical pressure. 20-day momentum is running at -2.87%, with price is trading in the lower part of its roughly 52-week range (3.29–6.84), while ATR14 volatility is elevated at roughly 6.86% of price. RSI(14) is 40.4, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Nearby upside pressure sits around 3.89. A decisive move through that level would improve the short-term picture. On the fundamentals side, the latest snapshot shows Net income: -644.76M · EPS (basic): -1.44. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

RXRX Chart